Last reviewed · How we verify
Ultram — Competitive Intelligence Brief
marketed
Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor
Pain
Live · refreshed every 30 min
Target snapshot
Ultram (tramadol) — Janssen.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ultram TARGET | tramadol | Janssen | marketed | Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor | ||
| MS Contin | morphine sulfate | Generic (multiple manufacturers) | marketed | Opioid analgesic | Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor | 1941-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — MS Contin · 7955619 · Formulation · US
- — MS Contin · 10314788 · Formulation · US
- — MS Contin · 9044402 · Formulation · US
- — MS Contin · 9549899 · Formulation · US
- — MS Contin · 9248229 · Formulation · US
- — MS Contin · 9192608 · Method of Use · US
- — MS Contin · 9072781 · Formulation · US
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
Cite this brief
Drug Landscape (2026). Ultram — Competitive Intelligence Brief. https://druglandscape.com/ci/tramadol. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab